Steve Schonfeld’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-171,170
Closed -$3.4M 2707
2023
Q1
$3.4M Buy
+171,170
New +$2.96M 0.03% 547
2022
Q4
Sell
-15,949
Closed -$220K 3223
2022
Q3
$220K Buy
+15,949
New +$237K ﹤0.01% 2288
2022
Q2
Sell
-9,800
Closed -$222K 3213
2022
Q1
$222K Buy
+9,800
New +$190K ﹤0.01% 1884
2021
Q3
Sell
-5,400
Closed -$230K 2590
2021
Q2
$230K Buy
+5,400
New +$211K ﹤0.01% 1606
2020
Q4
Sell
-13,831
Closed -$545K 1965
2020
Q3
$545K Buy
13,831
+6,920
+100% +$223K 0.01% 886
2020
Q2
$218K Buy
+6,911
New +$258K 0.01% 1082
2020
Q1
Sell
-5,565
Closed -$270K 1632
2019
Q4
$270K Buy
+5,565
New +$253K 0.01% 1025
2019
Q2
Sell
-6,000
Closed -$232K 1327
2019
Q1
$232K Buy
+6,000
New +$203K 0.01% 905
2017
Q4
Sell
-32,428
Closed -$913K 925
2017
Q3
$913K Buy
+32,428
New +$986K 0.08% 282
2017
Q2
Sell
-20,162
Closed -$571K 822
2017
Q1
$571K Buy
20,162
+10,380
+106% +$276K 0.06% 350
2016
Q4
$236K Buy
+9,782
New +$240K 0.03% 470

Other funds holding CSII

Steve Schonfeld's CSII Position: Q2 2023 in Review

Steve Schonfeld sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 171,170 shares — an estimated $3.4M sold.

Steve Schonfeld first reported a position in CSII in Q4 2016 and held it in 11 quarters. The position peaked at $3.4M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Steve Schonfeld reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Steve Schonfeld sold 171,170 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $3.4M.
  • Steve Schonfeld first reported a position in Cardiovascular Systems, Inc. in Q4 2016 and held it in 11 quarters.
  • Steve Schonfeld's Cardiovascular Systems, Inc. position peaked at $3.4M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.